부산대학교 도서관

ABSTRACTIntroductionSplenic abscesses are a rare medical entity with high mortality, with Clostridium perfringensbeing an exceptional pathogen. We present the first case describing an abscess of the spleen in a patient undergoing treatment with adalimumab, an anti-tumour necrosis factor commonly used in inflammatory bowel diseases.PatientWe describe the case of a 73-year-old woman, treated with adalimumab therapy, who was found to have a splenic abscess, caused by C. perfringens.ResultAfter antibiotic treatment and percutaneous drainage, the patient recovered both clinically and radiographically.DiscussionWe reviewed literature about C. perfringenssplenic abscesses. In all cases identified, a splenectomy was performed. This is the first case description of splenic abscess caused by C. perfringenswhere a percutaneous drainage was performed, leading to complete recovery in our patient. This seems to indicate that a splenectomy is not necessary in all C. perfringenssplenic abscesses.